SBC Medical Invests in NeuroBrain Dynamics to Co-Develop Six Medical AI Tools

SBC Medical Group Holdings Incorporated announced a capital and business alliance with Taipei-based NeuroBrain Dynamics Inc. on November 13, 2026, to co-develop six medical AI tools, and made a minority equity investment in the company. Business Wire reported the agreement, which also gives SBC Medical priority sales rights for NeuroBrain Dynamics products in Japan and South Korea.

How the Six AI Tools Work

The alliance covers two suites of generative AI solutions for SBC Medical's network of 287 clinics in Japan and overseas. The revenue-growth suite includes an AI concierge guidance tool that analyzes each customer's visit and treatment history and displays the information a concierge needs on screen, and a history-based recommendation feature for the MySBC booking system that suggests follow-up appointments from usage history. Both are co-developed on NeuroBrain Dynamics' Argon platform.

The cost-reduction suite covers AI-assisted electronic medical records that convert consultation dialogue into structured SOAP drafts using speech recognition, AI smart shift scheduling that maps customer demand against labor laws and clinic rules, and a Clinic Promotion Planner that generates promotional images for social media with automated checks against internal guidelines. A sixth solution, sovereign LLM infrastructure with NeuroBrain Dynamics' Bromine security monitoring, continuously monitors AI inputs for potential data leakage risks.

SBC Medical plans to offer NeuroBrain Dynamics' existing products to external medical institutions in Japan and South Korea, establishing a business-to-business revenue stream. NeuroBrain Dynamics, founded in June 2024, has deployed enterprise AI systems across more than 100 companies in the Asia-Pacific region and operates in seven hub cities, according to its company profile.

Yoshiyuki Aikawa, CEO of SBC Medical, said: "Across a 287-clinic network, even micro efficiencies scale into significant potential earnings power." Jeff Chuang, Chairman and CEO of NeuroBrain Dynamics, said the companies will build medical AI solutions "that achieve both safety and profitability, and bring them to Japan, South Korea, and markets across Asia."

SBC Medical's Growth Targets Before the Alliance

SBC Medical reported second-quarter 2026 financial results showing a 13% year-over-year increase in total revenues to $49 million and a 335% surge in net income to $11 million, according to Gurufocus. The company also outlined a strategic target to expand its network to 1,000 clinics by 2035 and identified an annual fee upside of $15 million associated with the growth plan, Seeking Alpha reported.

When the AI Tools Reach Clinics

SBC Medical will validate each AI module, with rollout for the AI Concierge Guidance Support Tool, the MySBC history-based recommendation feature and the Clinic Promotion Planner scheduled across the clinic network starting mid-2027. Accuracy testing for the AI-assisted electronic medical records is scheduled for completion via a proof of concept by year-end 2026, beginning in orthopedics.